Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1610073 | 0.82 | ESR1 (0.41) | TAAR1ACHETSHRMAPTGAA | |
| SCHEMBL1988589 | 0.78 | TAAR1 (0.48) | TAAR1ACHETSHRCHRM2PTGS1 | |
| SCHEMBL1611530 | 0.77 | TAAR1 (0.54) | TAAR1ACHETSHRCHRM2PTGS1 | |
| SCHEMBL28958193 | 0.76 | TAAR1 (0.46) | TAAR1ACHETSHRCHRM2PTGS1 | |
| SCHEMBL6085811 | 0.76 | TAAR1 (0.46) | TAAR1ACHETSHRCHRM2PTGS1 | |
| SCHEMBL87998 | 0.76 | GABRA1 (0.47) | TAAR1ACHETSHRCHRM2PTGS1 | |
| SCHEMBL29767673 | 0.76 | TAAR1 (0.46) | TAAR1ACHETSHRCHRM2PTGS1 | |
| SCHEMBL27579518 | 0.76 | TAAR1 (0.46) | TAAR1ACHETSHRCHRM2PTGS1 | |
| SCHEMBL168282 | 0.76 | TAAR1 (0.46) | TAAR1ACHETSHRCHRM2PTGS1 | |
| SCHEMBL16167522 | 0.74 | TAAR1 (0.56) | TAAR1ACHETSHRCHRM2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-2248818-A1 | ORGANIC SEMICONDUCTOR MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
| US-7071359-B1 | Neuropathy improvers containing nitrogenous compounds as the active ingredient | TEIJIN LIMITED (JP) | 2006-07-04 | — | — | US | disclosed |
| EP-1201235-B1 | NEUROPATHY IMPROVERS CONTAINING NITROGENOUS COMPOUNDS AS THE ACTIVE INGREDIENT | TEIJIN LTD (JP) | 2005-10-12 | — | — | EP | disclosed |
| EP-1201235-A1 | NEUROPATHY IMPROVERS CONTAINING NITROGENOUS COMPOUNDS AS THE ACTIVE INGREDIENT | TEIJIN LIMITED (JP) | 2002-05-02 | — | — | EP | disclosed |
| EP-0387196-B1 | Complexes with optically active ligands, process for their preparation and their use | CIBA GEIGY AG (CH) | 1995-05-03 | — | — | EP | disclosed |
| EP-0254685-B1 | Complexes with optically active sugar ligands, process for their preparation and their use | CIBA GEIGY AG (CH) | 1994-04-13 | — | — | EP | disclosed |
| WO-1993011167-A1 | POLYMERISATION PROCESS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-06-10 | — | — | WO | disclosed |
| US-5047557-A | Complexes having optically active ligands, a process for their preparation and their use | CIBA-GEIGY CORPORATION (US) | 1991-09-10 | — | — | US | disclosed |
| US-4981827-A | Catalysts | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-01-01 | — | — | US | disclosed |
| EP-0387196-A1 | Complexes with optically active ligands, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1990-09-12 | — | — | EP | disclosed |
| US-4914196-A | CHIRAL REACTANTS FOR ALDEHYDES, KETONES, N-SUBSTITUTED IMINES | CIBA-GEIGY CORPORATION (US) | 1990-04-03 | — | — | US | disclosed |
| US-4826965-A | Metal complexes containing optically active sugar ligands, a process for their preparation and their use as chiral reactants for synthesis of alcohols and amines | CIBA-GEIGY CORPORATION (US) | 1989-05-02 | — | — | US | disclosed |
| EP-0254685-A2 | Complexes with optically active sugar ligands, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1988-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | TAAR1 772/4885ACHE 3944/4885TSHR 2994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.